Skip to main content

Are you Dr. Pinsker?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 50 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    2219 Bath Street
    William Sansum Diabetes Center
    Santa Barbara, CA 93105
    Phone+1 805-682-7640
    Fax+1 805-682-3332
  • Is this information wrong?

Summary

  • Dr. Jordan Pinsker, MD is a pediatric endocrinologist in Santa Barbara, California. He is currently licensed to practice medicine in California, Hawaii, and Texas.

Education & Training

  • National Capital Consortium
    National Capital ConsortiumFellowship, Pediatric Endocrinology, 2004 - 2007
  • San Antonio Uniformed Services Health Education Consortium
    San Antonio Uniformed Services Health Education ConsortiumResidency, Pediatrics, 2001 - 2004
  • Albany Medical College
    Albany Medical CollegeClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - 2024
  • HI State Medical License
    HI State Medical License 2008 - 2016
  • TX State Medical License
    TX State Medical License 2002 - 2009
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Endocrinology
  • American Board of Preventive Medicine Clinical Informatics

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Tandem Diabetes Care Announces Control-IQ Technology Meta-Analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes
    Tandem Diabetes Care Announces Control-IQ Technology Meta-Analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 DiabetesApril 17th, 2023
  • Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ Technology
    Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ TechnologyNovember 10th, 2022
  • Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with Diabetes
    Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with DiabetesJune 6th, 2022
  • Join now to see all